Therapeutic pathology
71 – 80 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation : Implications for risk stratification of bladder cancer
- Contribution to journal › Article
-
Mark
Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma
- Contribution to journal › Article
-
Mark
Healthy lifestyle and the risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition study
- Contribution to journal › Article
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
- Contribution to journal › Article
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
- Contribution to journal › Article
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
- Contribution to journal › Article
-
Mark
Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
- Contribution to journal › Article
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
- Contribution to journal › Article
